Approval · Notice of Compliance 17234 · 2015
RESFLOR: Notice of Compliance 17234
Issued August 27, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17234
- Date
- August 27, 2015
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling update
- Therapeutic class
- Non-steroidal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RESFLOR | 02330997 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 16.5 MG per ML
- FLORFENICOL 300 MG per ML